- Home
- RDNT vs AB Comparison
RDNT vs AB Comparison
Compare RDNT & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDNT
- AB
- Stock Information
- Founded
- RDNT 1985
- AB 1987
- Country
- RDNT United States
- AB United States
- Employees
- RDNT N/A
- AB N/A
- Industry
- RDNT Medical Specialities
- AB Investment Managers
- Sector
- RDNT Health Care
- AB Finance
- Exchange
- RDNT Nasdaq
- AB Nasdaq
- Market Cap
- RDNT 4.2B
- AB 4.5B
- IPO Year
- RDNT 1986
- AB 1988
- Fundamental
- Price
- RDNT $57.41
- AB $42.87
- Analyst Decision
- RDNT Strong Buy
- AB Hold
- Analyst Count
- RDNT 5
- AB 5
- Target Price
- RDNT $69.60
- AB $40.00
- AVG Volume (30 Days)
- RDNT 675.7K
- AB 175.8K
- Earning Date
- RDNT 08-10-2025
- AB 07-24-2025
- Dividend Yield
- RDNT N/A
- AB 7.60%
- EPS Growth
- RDNT N/A
- AB 17.05
- EPS
- RDNT N/A
- AB 3.37
- Revenue
- RDNT $1,869,356,000.00
- AB N/A
- Revenue This Year
- RDNT $9.36
- AB N/A
- Revenue Next Year
- RDNT $8.35
- AB $6.29
- P/E Ratio
- RDNT N/A
- AB $12.74
- Revenue Growth
- RDNT 12.76
- AB N/A
- 52 Week Low
- RDNT $45.00
- AB $30.57
- 52 Week High
- RDNT $93.65
- AB $43.30
- Technical
- Relative Strength Index (RSI)
- RDNT 51.66
- AB 65.84
- Support Level
- RDNT $55.99
- AB $41.66
- Resistance Level
- RDNT $58.92
- AB $41.63
- Average True Range (ATR)
- RDNT 2.13
- AB 0.82
- MACD
- RDNT 0.05
- AB 0.15
- Stochastic Oscillator
- RDNT 50.19
- AB 85.42
About RDNT RadNet Inc.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (41%), and private (18%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of April 2025, the company had $781 billion in managed assets, composed primarily of fixed-income (38% of AUM) and equity (40%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.